What's more, percentage of PD-1+ cells, the major immune checkpoint, fell down and granzyme B (GZMB) expression in CD8+ T cells was dramatically enhanced (Figure 5G-H), indicating improved anti-tumor effects. This evidence concerns the gene CD8A and neoplasm.